Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy

Ito,Keiichi; Asakuma,Junichi; Kuroda,Kenji; Tachi,Kazuyoshi; Sato,Akinori; Horiguchi,Akio; Seguchi,Kenji; Asano,Tomohiko

doi:10.3892/mco.2016.754

Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy

Authors:
- Keiichi Ito
- Junichi Asakuma
- Kenji Kuroda
- Kazuyoshi Tachi
- Akinori Sato
- Akio Horiguchi
- Kenji Seguchi
- Tomohiko Asano
View Affiliations

Affiliations: Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359‑8513, Japan
Published online on: January 28, 2016 https://doi.org/10.3892/mco.2016.754
Pages: 530-536

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The prediction of extraurothelial recurrence (EUR) before radical nephroureterectomy (RNU) is difficult for patients with upper tract urothelial carcinoma. If EUR can be predicted preoperatively, it may be possible to determine the need for neoadjuvant chemotherapy or the surgical strategy. Our previous study identified preoperative risk factors for EUR in ureteral cancer, while the present study identified preoperative risk factors for EUR in renal pelvic cancer (RPC). The preoperative factors were reviewed in 71 N0M0 patients with RPC treated by RNU between 1999 and 2013. Preoperative clinical background data, laboratory test results, including inflammatory indices, lactate dehydrogenase (LDH), and estimated glomerular filtration rate, and radiological findings were subjected to multivariate analyses to identify independent predictive factors for EUR. The 3‑year EUR‑free survival (EURFS) rate was 81.9%, and univariate analysis showed that clinical T (cT) stage ≥3, white blood cell counts ≥7600/µl, neutrophil counts ≥4,500/µl, neutrophil-to-lymphocyte ratio ≥2.0, and LDH ≥210 IU/l were significantly associated with EURFS. Additionally, a cT stage ≥3 (P=0.0244) and LDH ≥210 IU/l (P=0.0322) were independent predictors for EUR. When patients were stratified into three groups according to the number of risk factors, the 3‑year EURFS rates were 94.5, 76.3, and 33.3% for the low‑, intermediate‑, and high‑risk patient groups, respectively. In conclusion, cT stage ≥3 and LDH ≥210 IU/l were preoperative predictive factors of EUR in patients with RPC. High‑risk patients may be candidates for neoadjuvant chemotherapy and low‑risk patients may be candidates for RNU without lymph node dissection.

View Figures

View References

1	Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H and Kihara K: Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol. 178:2291–2296; discussion 2296. 2007. View Article : Google Scholar : PubMed/NCBI
2	Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, et al: Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 27:612–618. 2009. View Article : Google Scholar : PubMed/NCBI
3	Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD and Wood CG: Upper Tract Urothelial Carcinoma Collaboration. The Upper Tract Urothelial Carcinoma Collaboration: Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration. Cancer. 115:1224–1233. 2009. View Article : Google Scholar : PubMed/NCBI
4	Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, et al: Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 57:575–581. 2010. View Article : Google Scholar : PubMed/NCBI
5	Hashimoto T, Ohno Y, Nakashima J, Gondo T, Ohori M and Tachibana M: Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World J Urol. 31:953–958. 2013. View Article : Google Scholar : PubMed/NCBI
6	Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, et al: Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 184:69–73. 2010. View Article : Google Scholar : PubMed/NCBI
7	Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, et al: Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 184:453–458. 2010. View Article : Google Scholar : PubMed/NCBI
8	Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M, Bochner BH, Coleman J and Dalbagni G: Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 109:77–82. 2012. View Article : Google Scholar : PubMed/NCBI
9	Park S, Hong B, Kim CS and Ahn H: The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 171:621–625. 2004. View Article : Google Scholar : PubMed/NCBI
10	Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I and Ozen H: Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 176:48–52. 2006. View Article : Google Scholar : PubMed/NCBI
11	Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S, Sato A, Horiguchi A, Seguchi K and Asano T: Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy. J Urol. 191:1685–1692. 2014. View Article : Google Scholar : PubMed/NCBI
12	Sobin LH, Gospodarowicz M and Wittekind C: Kidney. TNM classification of malignant tumors (7th). (New York, NY). Wiley-Blackwell. 258–p261. 2009.
13	Ohno Y, Nakashima J, Ohori M, Hatano T and Tachibana M: Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol. 184:873–878. 2010. View Article : Google Scholar : PubMed/NCBI
14	Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A and Ferrara J: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 17:2530–2540. 1999.PubMed/NCBI
15	Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y and Kihara K: The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 100:269–273. 2007. View Article : Google Scholar : PubMed/NCBI
16	Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, et al: The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A multi-institutional study. Eur Urol. 65:227–234. 2014. View Article : Google Scholar : PubMed/NCBI
17	Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H, et al: A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol. 21:4041–4048. 2014. View Article : Google Scholar : PubMed/NCBI
18	Ito Y, Kikuchi E, Tanaka N, Miyajima A, Mikami S, Jinzaki M and Oya M: Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 185:1621–1626. 2011. View Article : Google Scholar : PubMed/NCBI
19	Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, et al: Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: Insights from the upper tract urothelial carcinoma collaboration. bju int. 108:1286–1291. 2011. View Article : Google Scholar : PubMed/NCBI
20	Kitamura H, Igarashi M, Tanaka T, Shindo T, Masumori N, Tamakawa M, Kawaai Y and Tsukamoto T: A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy. Jpn J Clin Oncol. 42:1192–1196. 2012. View Article : Google Scholar : PubMed/NCBI
21	Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL and Bellmunt J: A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol. 66:529–541. 2014. View Article : Google Scholar : PubMed/NCBI